TechLink – Product innovation doesn’t have to stop because of R&D budget cuts

The coronavirus pandemic has educated the public on the fact that the discovery and development of pharmaceutical and health care products is a long and expensive process.

And while most business leaders say that innovation is a top priority, the number of businesses saying they don’t plan to invest in innovation has jumped from 8% to 25% since the coronavirus pandemic began, according to survey research reported by Sifted.